EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

Wednesday, June 17, 2026GlobalData HealthcareView original

BMS shared Phase III data for mezigdomide and Phase I data for a CAR-T therapy at this year’s EHA conference.

Read the full article on the original site.